Lijing Li

Lijing Li currently serves as the Global Head of CMC Technical Operation at Sardocor, having joined in August 2022. Previously, Lijing held multiple leadership roles at ASC Therapeutics, including Senior Director and Director of CMC Head for Cell and Gene Therapy, where expertise in AAV viral vector, process development, and manufacturing was demonstrated. Lijing's career includes significant contributions at Orchard Therapeutics, Adicet Bio, Inc., and Epeius Biotechnologies Corp., with a focus on viral vector processes and allogeneic CAR-T engineering. Early experience at City of Hope National Medical Center involved setting up gene and cell therapy platforms, leading clinical trials, and overseeing large-scale manufacturing processes. Lijing holds a Master’s degree in Biology from the University of Southern California and a Bachelor’s degree in Biology from Xiamen University, along with educational experience from the University of Louisiana Monroe.